About aclarion inc - ACON
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
ACON At a Glance
Aclarion, Inc.
8181 Arista Place
Broomfield, Colorado 80021
| Phone | 1-833-275-2266 | Revenue | 75.73K | |
| Industry | Packaged Software | Net Income | -7,233,629.00 | |
| Sector | Technology Services | 2025 Sales Growth | 65.624% | |
| Fiscal Year-end | 12 / 2026 | Employees | 11 | |
| View SEC Filings |
ACON Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 32.317 |
| Price to Book Ratio | 0.306 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 1.406 |
| Enterprise Value to Sales | -126.679 |
| Total Debt to Enterprise Value | N/A |
ACON Efficiency
| Revenue/Employee | 6,884.545 |
| Income Per Employee | -657,602.636 |
| Receivables Turnover | 2.552 |
| Total Asset Turnover | 0.005 |
ACON Liquidity
| Current Ratio | 14.806 |
| Quick Ratio | 14.806 |
| Cash Ratio | 14.381 |
ACON Profitability
| Gross Margin | -291.269 |
| Operating Margin | -9,312.545 |
| Pretax Margin | -9,551.867 |
| Net Margin | -9,551.867 |
| Return on Assets | -52.368 |
| Return on Equity | -104.796 |
| Return on Total Capital | -56.358 |
| Return on Invested Capital | -104.796 |
ACON Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |